**Core Concept**
Pneumococcal lobar pneumonia, caused by Streptococcus pneumoniae, requires prompt antibiotic treatment to prevent complications and mortality. The choice of antibiotic is crucial, considering the pathogen's characteristics and resistance patterns.

**Why the Correct Answer is Right**
The drug of choice for acute pneumococcal lobar pneumonia is a beta-lactam antibiotic that targets the bacterial cell wall, such as penicillin. Penicillin inhibits the enzyme transpeptidase, essential for bacterial cell wall synthesis, leading to cell lysis and death. This mechanism is effective against S. pneumoniae, making penicillin a first-line treatment.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a beta-lactam antibiotic, which is the preferred class for treating pneumococcal infections.

**Option B:** This option is incorrect because it suggests a macrolide antibiotic, which may not be effective against penicillin-resistant S. pneumoniae strains.

**Option C:** This option is incorrect because it implies the use of a fluoroquinolone antibiotic, which may not be the first choice for treating pneumococcal lobar pneumonia.

**Clinical Pearl / High-Yield Fact**
When treating pneumococcal infections, it's essential to consider local resistance patterns and choose an antibiotic that targets the specific strain. Penicillin remains a reliable option, but resistance rates can vary geographically.

**Correct Answer:** C. Penicillin.